Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Zanubrutinib + CAR T-Cell Therapy for Richter's Syndrome
Recruiting1 awardPhase 2
Columbus, Ohio
This trial tests a combination of drugs to treat Richter's syndrome, a type of cancer of the lymph nodes. The drugs stop abnormal proteins that tell cancer cells to multiply & also change immune cells to attack cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service